<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02450604</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2014/23</org_study_id>
    <nct_id>NCT02450604</nct_id>
  </id_info>
  <brief_title>Prevalence of Fabry's Disease in a Population of Patients With Chronic Pain</brief_title>
  <acronym>DOUFABIS</acronym>
  <official_title>Prevalence of Fabry's Disease in a Population of Patients With Chronic Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fabry disease is a rare inherited metabolic disorder that predominantly affects heart,
      kidneys and nervous system. Fabry disease has been searched in series of patients presenting
      different isolated signs caused by the affection of one of these organs. Acroparesthesias and
      chronic crises of pain of different origins are reported in the large majority of patients
      during the progression of the disease. Moreover, this signs are frequently inaugurating the
      disease. The investigators have previously performed a preliminary single-center study which
      permitted to identify one female patient with Fabry disease in a series of 147 consecutive
      patients with chronic pain tested. The investigators now propose to confirm the results of
      our preliminary study. The investigators plan to evaluate the prevalence of Fabry disease in
      a series of 1000 patients suffering from chronic pains of undetermined aetiology and
      consecutively recruited.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fabry disease (FD) is a rare X-linked multisytemic lysosomal disorder caused by
      alpha-galactosidase deficiency. Globotriaosylcéramide (Gb3) deposits are observed in almost
      all tissues examined. Signs of the disease appear earlier and are more severe in affected
      males than in females. Myocardiopathy, renal failure and neurological signs including chronic
      pain and peripheral neuropathies are the most frequent signs. The availability of two
      enzymatic replacement therapies now provides a specific and effective treatment for patients.
      The prevalence of FD is estimated between 1/40,000 and 1/117,000. The frequency of Fabry
      disease has previously been estimated in several series of patients presenting one single
      sign, ie renal failure, hypertrophic myocardiopathy and early onset stroke. However, no data
      are available about the prevalence of FD in populations of patients suffering from chronic
      pains of unknown origin.

      The diagnosis of FD will be performed by standard procedures following international
      recommendations. These require the search for a deficiency of alphagalactosidase A activity
      on leucocytes in males and genetic analysis of the GLA gene in females (Germain et al. 2010).

      The patients in whom the diagnosis of FD is established during this study, will be call in
      for an additional visit in the Investigating Centre in order to confirm the diagnosis and
      propose suitable assessment and care.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnosis of Fabry disease in one patient suffering from chronic pains</measure>
    <time_frame>J1 to 2 months after inclusion</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Fabry's Disease</condition>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Patients with chronic pains of unknown aetiology</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Diagnosis of Fabry disease</intervention_name>
    <description>The diagnosis of Fabry disease necessitates biochemical enzymatic measures of alphagalactosidase A activity in males, and genetic analysis using direct sequencing of GLA in females.</description>
    <arm_group_label>Patients with chronic pains of unknown aetiology</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients of both sex,

          -  aged from 6 to 80,

          -  with chronic pains of unknown aetiology including: acroparesthesias, and/or pain
             crises evolving more than 3 months, continued neuropathic evolving more than 3 months,
             and/or multiple pains evolving more than 3 months and/or recurrent abdominal crises of
             pain who come for a clinical visit in the pain Centres of France.

        Exclusion Criteria:

          -  chronic pain of known cause
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cyril GOIZET</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Bordeaux</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cyril GOIZET</last_name>
    <phone>05 56 79 59 52</phone>
    <phone_ext>+33</phone_ext>
    <email>cyril.goizet@chu-bordeaux.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cs douleur chronique GHSR, CHU Sud Réunion</name>
      <address>
        <city>Saint Pierre</city>
        <state>La Réunion</state>
        <zip>97448</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Edwige CAND</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CeRCa, Unité de Neuromyologie, CHU de Fort de France</name>
      <address>
        <city>Fort de France</city>
        <state>Martinique</state>
        <zip>97261</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Elisabeth SARRAZIN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Douleurs Chroniques, CH de la Côte Basque</name>
      <address>
        <city>Bayonne</city>
        <zip>64109</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Laurence DAVID</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Douleurs Chroniques, CHU de Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cyril GOIZET, Pr</last_name>
      <phone>+33 5 56 79 59 52</phone>
      <email>cyril.goizet@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Virginie DOUSSET</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de médecine Polyvalent, CH de La Dracénie</name>
      <address>
        <city>Draguignan</city>
        <zip>83007</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Virginie PIANO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Anesthésie, Hôpital Raymond Poincaré</name>
      <address>
        <city>Garches</city>
        <zip>92380</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Valéria MARTINEZ</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre de la douleur de l'Adulte et de l'Enfant, CHU de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Caroline MAINDET-DOMINICI</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Médecine - Consultations Douleur, CH de La Réole</name>
      <address>
        <city>La Reole</city>
        <zip>33192</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Maud MARTIAL</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Unité Douleur et Soins Palliatifs, CH La Rochelle-Réaunis</name>
      <address>
        <city>La Rochelle</city>
        <zip>17019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Géraldine DE MONTGAZON</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pole enfant - CETD Salengro, CHRU de Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Christian LUCAS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pôle Anesthésie Consultation douleur, CHRU de Lille</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Jean-Michel WATTIER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CETD La Timone, AP-HM</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Stéphanie RANQUE GARNIER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre d'Analgésie, CHRU Lapeyronie</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Frédéric BERNARD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre d'Evaluation et de Traitement de la Douleur, CHU de Nîmes</name>
      <address>
        <city>Nimes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Eric VIEL</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Médecine de la Douleur et de Médecine Palliative, Hôpital Lariboisière-APHP</name>
      <address>
        <city>Paris</city>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Alain SERRIE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de lutte contre la douleur et d'Anesthésie, CH Périgueux</name>
      <address>
        <city>Perigueux</city>
        <zip>24 019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Patrick LAFONT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service d'Explorations Fonctionnelles et Consultations Neurologiques, CH Lyon-Sud</name>
      <address>
        <city>Pierre Benite</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>GONNAUD Pierre-Marie</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Antidouleurs, CHU de Reims</name>
      <address>
        <city>Reims</city>
        <zip>51092</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Céline LISS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre de la Douleur, CHRU de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>André MULLER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre d'Analgésie Pédiatrique, Equipe Régionale Ressource en Soins Palliatifs-Equipe &quot; Enfant-Do &quot;, CHU de Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Agnès SUC</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre d'évaluation et de traitement de la Douleur, Hôpital Pierre-Paul Ricquet</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Nathalie CANTAGREL</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2015</study_first_submitted>
  <study_first_submitted_qc>May 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2015</study_first_posted>
  <last_update_submitted>August 19, 2016</last_update_submitted>
  <last_update_submitted_qc>August 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prevalence Study</keyword>
  <keyword>Fabry's disease</keyword>
  <keyword>Chronic pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Fabry Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

